GGrantIndex
Sort

40,608 grants matching prostate cancer

Role of Nuclear Pore-Regulated Mechanisms in Prostate Cancer Aggressiveness

$352,912
Veronica Rodriguez-Bravo · Mayo Clinic Rochester · R01 · FY2022 · CA

GENOMIC PREDICTORS OF CLINICAL OUTCOMES AND BENEFIT OF (CHEMO)HORMONAL THERAPY IN METASTATIC HORMONE SENSITIVE PROSTATE CANCER.

$352,846
Dana-Farber Cancer Institute, Inc. · · FY2020 · Defense Health Agency

DF/HCC SPORE in Prostate Cancer

$352,826
Philip W Kantoff · Dana-Farber Cancer Inst · P50 · FY2009 · CA

STRUCTURE AND FUNCTION OF HYALURONAN SYNTHASES

$352,816
Paul H Weigel · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2011 · GM

Mechanisms of pathogenesis in patient derived organoid models of prostate cancer

$352,810
Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

IOWA ONCOLOGY RESEARCH ASSOCIATION

$352,805
Iowa Oncology Research Association · U10 · FY2000 · CA

UFM1 signaling in DNA damage response and cancer therapy

$352,801
Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2019 · CA

Role of CPT1A as a lysine succinyltransferase in tumorigenesis

$352,801
Taro Hitosugi · Mayo Clinic Rochester · R01 · FY2019 · CA

Mechanism of non-oncogene addiction

$352,801
Mohammad Azam · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · CA

Role of RUNX2 in prostate cancer intratumoral androgen synthesis and progression

$352,801
Haojie Huang · Mayo Clinic Rochester · R01 · FY2019 · CA

Mechanism and role of aberrant AR activity in castration-resistant prostate cancer

$352,801
Haojie Huang · Mayo Clinic Rochester · R01 · FY2019 · CA

The JAZF1 Gene and Type 2 Diabetes

$352,800
Jeffrey Sklar · Yale University · R01 · FY2011 · DK

Self-Concept Organization Across the Adult Life Span

$352,778
University Of Florida · R01 · FY2004 · AG

ROLE OF HOMEODOMAIN GENES IN HUMAN PROSTATE CANCER

$352,771
University Of Colorado Denver · R01 · FY2003 · CA

Improving Efficacy of RNase Cancer Therapy by Pharmacokinetics

$352,751
Laura E Strong · Quintessence Biosciences, Inc. · R44 · FY2010 · CA

A new regulator for Wnt/beta-catenin signaling and prostate tumorigenesis

$352,711
Zijie Sun · Beckman Research Institute/City Of Hope · R01 · FY2015 · CA

Inflammation and cancer treatment

$352,708
David Wink · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Toward Selective Androgen Deprivation by Targeting Androgen Activation of SRF

$352,691
Hannelore Heemers · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · CA

Transgenic Mice as Models for Antivascular Therapy

$352,663
University Of Pennsylvania · R01 · FY2003 · CA

Transgenic Mice as Models for Antivascular Therapy

$352,663
University Of Pennsylvania · R01 · FY2004 · CA

Hormonal Carcinogenesis in Rb-knockout Mouse Prostate

$352,650
Vanderbilt University · U01 · FY2005 · CA

Physical and functional probing of DEAD-box proteins as general RNA chaperones

$352,639
Rick Russell · University Of Texas At Austin · R01 · FY2014 · GM

Diagnosis of Cancer in the Emergency Room - Explaining Persistent Disparities

$352,620
Caroline Avery Thompson · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA

Epigenetics/Translational Biomarkers (ETB) Core

$352,616
Christiane V. Lohr · Oregon State University · P01 · FY2011 · CA

An Immune Based Therapeutic Approach for Prostate Cancer

$352,615
Esteban Celis · Mayo Clinic Rochester · P50 · FY2009 · CA